Mobic and Neupro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic (meloxicam) and Neupro (rotigotine). Common drug interactions include acne among females and postoperative wound infection among males.

The phase IV clinical study analyzes what interactions people have when they take Mobic and Neupro. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

What is Neupro?

Neupro has active ingredients of rotigotine. It is often used in parkinson's disease. eHealthMe is studying from 11,393 Neupro users. Check the latest studies of Neupro.



On Jul, 14, 2026

38 people who take Mobic and Neupro together, and have interactions are studied.

Mobic and Neupro drug interactions.

What are the common drug interactions of Mobic and Neupro, by gender? *:

female:

  1. Acne (skin problems that cause pimples)
  2. Anxiety
  3. Blood pressure increased
  4. Chronic kidney disease
  5. Cystitis (inflammation of the wall of the bladder)
  6. Nausea (feeling of having an urge to vomit)
  7. Abdominal discomfort
  8. Anaphylactic reaction (serious allergic reaction)
  9. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  10. Dehydration (dryness resulting from the removal of water)

male:

  1. Postoperative wound infection
  2. Back pain
  3. Stomach discomfort (pain in abdomen)
  4. Suicide attempt
  5. Device dislocation
  6. Fatigue (feeling of tiredness)
  7. Gait disturbance
  8. Muscle rigidity (muscle stiffness)
  9. Rib fracture
  10. Scapula fracture (a fracture of the scapula, the shoulder blade)

What are the common drug interactions of Mobic and Neupro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Dehydration (dryness resulting from the removal of water)
  3. Local swelling (swelling at the site of some application of substance or injury)
  4. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  5. Renal impairment (severely reduced kidney function)
  6. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  7. Gambling
  8. Swelling

50-59:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Insomnia (sleeplessness)
  3. Iron deficiency anaemia
  4. Leukocytosis (increased white blood cells)
  5. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  6. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  7. Device dislocation
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Gait disturbance

60+:

  1. Postoperative wound infection
  2. Anaphylactic reaction (serious allergic reaction)
  3. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  4. Application site erythema (redness of the skin at application site)
  5. Headache (pain in head)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Weight decreased

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 50.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 13.16%
  3. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 3 people, 7.89%
  4. Stress And Anxiety: 3 people, 7.89%
  5. High Blood Cholesterol: 3 people, 7.89%
  6. Depression: 3 people, 7.89%
  7. Cough: 3 people, 7.89%
  8. Constipation: 3 people, 7.89%
  9. Sleep Disorder: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Neupro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mobic and Neupro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and rotigotine (the active ingredients of Mobic and Neupro, respectively), and Mobic and Neupro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: